Also some noticed how $MGNX temporarily halted their compassionate use program on clinicaltrials ahead of the data. When I saw it I asked an independent expert who does that for a living. She said it didn\'t matter and was nonpredictive and was right. A

Also, some noticed how $MGNX temporarily halted their compassionate use program on clinicaltrials ahead of the data. When I saw it, I asked an independent expert who does that for a living. She said it didn't matter and was nonpredictive, and was right. A

01:03 EST 24 Feb 2019 | Brad Loncar

Also, some noticed how $MGNX temporarily halted their compassionate use program on clinicaltrials ahead of the data. When I saw it, I asked an independent expert who does that for a living. She said it didn't matter and was nonpredictive, and was right. Another lesson learned.

More From BioPortfolio on "Also, some noticed how $MGNX temporarily halted their compassionate use program on clinicaltrials ahead of the data. When I saw it, I asked an independent expert who does that for a living. She said it didn't matter and was nonpredictive, and was right. A"